Dambkowski Carl's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Jul 3, 2025
- Accession no.
- 0001104659-25-065888
- Filed
- Jul 3, 2025
- Trade date
- Jul 2, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $455.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dambkowski CarlCIK 0001983476 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | Common Stock | MOption exerciseAcquired | +7,365 | $22.86 | +$168,363.9 | 249,088 | Direct | |
| Jul 2, 2025 | Common Stock | SSaleDisposed | −6,409 | $44.77 | −$286,930.93 | 242,679 | Direct | |
| Jul 2, 2025 | Common Stock | SSaleDisposed | −2,935 | $45.49 | −$133,513.15 | 239,744 | Direct | |
| Jul 2, 2025 | Common Stock | SSaleDisposed | −746 | $46.26 | −$34,509.96 | 238,998 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | Common Stock | MOption exerciseDisposed | −7,365 | $0.00 | $0 | 164,010 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.